📰 Resented News
Page 55 - Resented News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resented. Real-time updates on events, politics, business and more.
December 15, 2021
Lund, December 15, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that preclinical data on its candidate drug tasquinimod, a small molecule immunomodulator, are now available on the
December 14, 2021
JÖNKÖPING, Sweden, Dec. 14, 2021 /PRNewswire/ -- As previously communicated, the Board of Directors works together with the Group Management of ITAB Shop Concept AB (publ) ("ITAB") to formulate
December 14, 2021
Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Multiple Myeloma ...
December 14, 2021
Malaysian parts maker ATA IMS said on Tuesday it has asked for charges that it violated labour laws to be dropped, saying any infractions were caused by challenges presented during the pandemic.... | December 14, 2021
December 14, 2021
Enter below for the chance to win 2 tickets to George Thorogood & The Destroyers: Good To Be Bad Tour, presented by Lone Star 92.5!   Lone...
December 14, 2021
Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH CMMC assay, a Non-Invasive Liquid Biopsy for the
December 13, 2021
Certain anti-SL parties working to tarnish hard-earned peace - Def Secy Hiru News Most visited website in Sri Lanka,Sri Lanka Latest news updates from Sri Lanka. Sri Lanka News updates and discussions. Welcome to the No1 online news Site for Sri Lankans. A Rayynor Silva Holdings Company
December 13, 2021
Dubai - Andrey Guryev, Vice President and Trustee of the Russian Chess Federation and CEO of PhosAgro, presented the World Chess Championship trophy to Norwegian Grandmaster Magnus Carlsen. ... | December 13, 2021
December 12, 2021
Epizyme, Inc. , a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies against novel epigenetic targets, today presented updated safety and... | December 12, 2021
December 12, 2021
ELEVATE-RR head-to-head trial data also presented at ASH showed patients on ibrutinib experienced a 37% higher burden of adverse events of any grade while on treatment vs. patients on CALQUENCE ... | December 12, 2021